{"altmetric_id":1980251,"counts":{"readers":{"mendeley":4,"citeulike":0,"connotea":0},"total":{"posts_count":4},"twitter":{"unique_users_count":3,"unique_users":["UFPersonalMed","nathanseligson","Pharmaco_Genom"],"posts_count":4}},"citation":{"abstract":"The effects of CYP2C9*1\/*3 and *3\/*3 genotypes on the pharmacokinetics and pharmacodynamics of meloxicam were evaluated in healthy Korean subjects.","abstract_source":"pubmed","altmetric_jid":"4f6fa6343cf058f6100084d9","doi":"10.1097\/fpc.0000000000000025","first_seen_on":"2013-12-15T00:00:22+00:00","issns":["1744-6872"],"issue":"","journal":"Pharmacogenetics and Genomics","last_mentioned_on":1394241515,"links":["http:\/\/journals.lww.com\/jpharmacogenetics\/Abstract\/publishahead\/Strongly_increased_exposure_of_meloxicam_in.99482.aspx","http:\/\/journals.lww.com\/jpharmacogenetics\/Abstract\/2014\/02000\/Strongly_increased_exposure_of_meloxicam_in.3.aspx"],"pdf_url":"http:\/\/pdfs.journals.lww.com\/jpharmacogenetics\/9000\/00000\/Strongly_increased_exposure_of_meloxicam_in.99482.pdf","pmid":"24322170","pubdate":"2013-12-11T00:00:00+00:00","publisher_subjects":[{"name":"Genetics","scheme":"era"},{"name":"Pharmacology And Pharmaceutical Sciences","scheme":"era"}],"scopus_subjects":["Health Sciences","Medicine","Life Sciences","Biochemistry, Genetics and Molecular Biology"],"startpage":"","subjects":["geneticsmedical","pharmacology"],"title":"Strongly increased exposure of meloxicam in CYP2C9*3\/*3 individuals","type":"article","volume":"Publish Ahead of Print","mendeley_url":"http:\/\/www.mendeley.com\/research\/strongly-increased-exposure-meloxicam-cyp2c933-individuals"},"altmetric_score":{"score":1.5,"score_history":{"1y":0,"6m":0,"3m":0,"1m":0,"1w":0,"6d":0,"5d":0,"4d":0,"3d":0,"2d":0,"1d":0,"at":1.5},"context_for_score":{"all":{"total_number_of_other_articles":4505482,"mean":5.1017741758441,"rank":2008107,"this_scored_higher_than_pct":53,"this_scored_higher_than":2408123,"rank_type":"exact","sample_size":4505482,"percentile":53},"similar_age_3m":{"total_number_of_other_articles":123402,"mean":7.282422816671,"rank":49177,"this_scored_higher_than_pct":58,"this_scored_higher_than":71588,"rank_type":"exact","sample_size":123402,"percentile":58},"this_journal":{"total_number_of_other_articles":523,"mean":1.5985593869732,"rank":141,"this_scored_higher_than_pct":70,"this_scored_higher_than":369,"rank_type":"exact","sample_size":523,"percentile":70},"similar_age_this_journal_3m":{"total_number_of_other_articles":28,"mean":1.8712592592593,"rank":11,"this_scored_higher_than_pct":60,"this_scored_higher_than":17,"rank_type":"exact","sample_size":28,"percentile":60}}},"demographics":{"poster_types":{"member_of_the_public":2,"researcher":1},"users":{"twitter":{"cohorts":{"Members of the public":2,"Scientists":1}},"mendeley":{"by_status":{"Researcher":2,"Student  > Master":1,"Other":1},"by_discipline":{"Medicine and Dentistry":1,"Chemistry":2,"Business, Management and Accounting":1}}},"geo":{"twitter":{"US":2},"mendeley":{"US":2}}},"posts":{"twitter":[{"url":"http:\/\/twitter.com\/UFPersonalMed\/status\/420950925889372160","license":"public","citation_ids":[1980251],"posted_on":"2014-01-08T16:11:36+00:00","author":{"name":"UF Personalized Med","url":"https:\/\/ufhealth.org\/personalized-medicine","image":"https:\/\/pbs.twimg.com\/profile_images\/378800000629541288\/29a29e166219b15ce8b47854c1293153_normal.png","description":"The official Twitter account of the UF Health Personalized Medicine Program","id_on_source":"UFPersonalMed","tweeter_id":"1648177363","geo":{"lt":29.65163,"ln":-82.32483,"country":"US"},"followers":453},"tweet_id":"420950925889372160"},{"url":"http:\/\/twitter.com\/nathanseligson\/status\/420966300223938561","license":"public","rt":["UFPersonalMed"],"citation_ids":[1980251],"posted_on":"2014-01-08T17:12:41+00:00","author":{"name":"Nathan Seligson","url":"http:\/\/www.linkedin.com\/in\/nseligson","image":"https:\/\/pbs.twimg.com\/profile_images\/766714035643355136\/5l2Yf-qx_normal.jpg","description":"Passionate pharmacist; Heme\/Onc research fellow @ohiostate. My thoughts on leadership, PK\/PD\/Pgx, data analysis, translational research. Opinions are my own.","id_on_source":"nathanseligson","tweeter_id":"73279220","geo":{"lt":39.96118,"ln":-82.99879,"country":"US"},"followers":528},"tweet_id":"420966300223938561"},{"url":"http:\/\/twitter.com\/Pharmaco_Genom\/status\/442107077503107072","license":"public","citation_ids":[1980251],"posted_on":"2014-03-08T01:18:35+00:00","author":{"name":"Pharmacogen & Genom","image":"https:\/\/pbs.twimg.com\/profile_images\/2418255737\/FPC_thumb_squared_normal.jpg","description":"Pharmacogenetics and Genomics is devoted to the rapid publication of papers on genetic determinants in response to drugs & other chemicals in humans & animals.","id_on_source":"Pharmaco_Genom","tweeter_id":"708811801","geo":{"lt":null,"ln":null},"followers":348},"tweet_id":"442107077503107072"},{"url":"http:\/\/twitter.com\/Pharmaco_Genom\/status\/412009036402290688","license":"public","citation_ids":[1980251],"posted_on":"2013-12-14T23:59:43+00:00","author":{"name":"Pharmacogen & Genom","image":"https:\/\/pbs.twimg.com\/profile_images\/2418255737\/FPC_thumb_squared_normal.jpg","description":"Pharmacogenetics and Genomics is devoted to the rapid publication of papers on genetic determinants in response to drugs & other chemicals in humans & animals.","id_on_source":"Pharmaco_Genom","tweeter_id":"708811801","geo":{"lt":null,"ln":null},"followers":348},"tweet_id":"412009036402290688"}]}}